Not applicableStudy completedNCT06517277What this trial is testingHaemophilus Influenzae Pneumonia in AdultsWho this might be right forHaemophilus Influenzae Pneumonia Assistance Publique - Hôpitaux de Paris 203
Large-scale testing (Phase 3)Study completedNCT00514709What this trial is testingImmunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino InfantsWho this might be right forDiphtheriaTetanusPertussis+2 more Sanofi Pasteur, a Sanofi Company 1,843
Large-scale testing (Phase 3)Study completedNCT01019772What this trial is testingImmunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of AgeWho this might be right forInfectious Disease by Haemophilus Influenzae Type b LG Life Sciences 217
Testing effectiveness (Phase 2)Study completedNCT00135564What this trial is testingStudy to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy ToddlersWho this might be right forInfections, Meningococcal GlaxoSmithKline 500
Testing effectiveness (Phase 2)Study completedNCT01171989What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster DoseWho this might be right forTetanusDiphtheriaHaemophilus Influenzae Type b+4 more GlaxoSmithKline 391
Large-scale testing (Phase 3)UnknownNCT03402776What this trial is testingImpact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell TransplantationWho this might be right forHaemopoietic Stem Cell TransplantationAllograft University Hospital, Grenoble 200
Not applicableStudy completedNCT01204385What this trial is testingStudy to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi ArabiaWho this might be right forInfections, Streptococcal GlaxoSmithKline 66
Post-approval studies (Phase 4)Study completedNCT04535037What this trial is testingEvaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and ToddlersWho this might be right forDiphtheria GlaxoSmithKline 500
Large-scale testing (Phase 3)UnknownNCT02560272What this trial is testingSafety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-driedWho this might be right forHaemophilus Influenzae Type b Infections Beijing Minhai Biotechnology Co., Ltd 1,560
Testing effectiveness (Phase 2)Study completedNCT00134719What this trial is testingHib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate VaccinesWho this might be right forNeisseria MeningitidisHaemophilus Influenzae Type b GlaxoSmithKline 1,104
Large-scale testing (Phase 3)Study completedNCT01337167What this trial is testingSafety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)Who this might be right forBacterial InfectionsVirus Diseases Merck Sharp & Dohme LLC 1,473
Large-scale testing (Phase 3)Study completedNCT00317109What this trial is testingStudy to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed SubjectsWho this might be right forInfections, Meningococcal GlaxoSmithKline 168
Testing effectiveness (Phase 2)Study completedNCT00831311What this trial is testingStudy of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean InfantsWho this might be right forDiphtheriaTetanusPertussis+2 more Sanofi Pasteur, a Sanofi Company 624
Large-scale testing (Phase 3)Study completedNCT01457508What this trial is testingImmunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered SeparatelyWho this might be right forHepatitis BDiphtheriaHaemophilus Influenzae Type b (Hib)+3 more GlaxoSmithKline 440
Large-scale testing (Phase 3)Study completedNCT00326118What this trial is testingStudy in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.Who this might be right forHaemophilus Influenzae Type bNeisseria Meningitidis GlaxoSmithKline 433
Early research (Phase 1)Study completedNCT05401305What this trial is testingSafety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type bWho this might be right forHaemophilus Influenzae InfectionVaccines St. Petersburg Research Institute of Vaccines and Sera 60
Large-scale testing (Phase 3)Study completedNCT00453570What this trial is testingImmunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 MonthsWho this might be right forDiphtheriaTetanusHaemophilus Influenzae Type b+2 more Sanofi 792
Not applicableStudy completedNCT03870061What this trial is testingEvaluation of an Infant Immunization Encouragement Program in NigeriaWho this might be right forTuberculosisDiphtheriaTetanus+8 more GiveWell 5,187
Large-scale testing (Phase 3)Study completedNCT00317187What this trial is testingSafety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.Who this might be right forHepatitis BDiphtheriaWhole Cell Pertussis+2 more GlaxoSmithKline 500
Not applicableEnded earlyNCT01292213What this trial is testingIdentify and Characterise Bacteria Causing Chronic Cough Among Children in United KingdomWho this might be right forInfections, Respiratory Tract GlaxoSmithKline 19